 |
| Market Responds Positively to TRTC News |
|
 Hot Stock to Watch |
Company: Terra Tech Corp (OTCQB: TRTC)
|
Last:
Price: 0.515
Change (%): + 0.115 (28.75)
Volume: 8,850,913 |
 |
Terra Tech Corp. Enters into Strategic Partnership with Inergetics to Develop a New Line of CBD Based Nutritional Supplements
Irvine, Feb. 4, 2014 (GLOBE NEWSWIRE) - Terra Tech Corp (TRTC), through their subsidiary GrowOp Technology, today announced it has entered into a strategic partnership with Inergetics, Inc. (NRTI), a leading developer of nutritional supplements, to jointly develop a line of natural Cannibidiol based nutritional supplements.
The strategic partnership will combine Inergetics’s proven expertise in successfully developing and marketing innovative nutritional supplements that help consumers lead better and healthier lives with Terra Tech Corp’s agricultural expertise and established distribution network of dispensaries in legalized medical cannabis markets.
The featured active ingredient in this new product line will be Cannibidiol (CBD), a non-psychoactive component of cannabis that possesses a wide range of therapeutic benefits. The supplements will be initially marketed to consumers of medical cannabis in legally approved markets who suffer from ailments that can benefit from CBD’s pain management and other therapeutic properties. To date, 20 states and the District of Columbia have enacted laws to legalize medical marijuana.
“We’re pleased to be entering into this strategic partnership with Terra Tech and we look forward to developing a unique supplement line to help patients manage their pain,” said Inergetics CEO Mike James. “This partnership will help Inergetics expand our product line into pain management supplements for consumers who are looking to address these symptoms while improving their quality of life.”
Continue Reading
|
  |
IMPORTANT DISCLAIMER - PLEASE READ THOROUGHLY
SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that the information is accurate. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from SmallCapVoice.com. You may opt out of our distribution list at any time by clicking on the "unsubscribe" link below. Link to full disclosure about compensation paid to SmallCapVoice.com, Inc. by companies featured on our website or in our e-mail communications. |
About Penny Stocks |
|
|
